Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons

Journal of Neurophysiology

Volumn 101, Issue 5, 2009, Pages 2230-2238

  Ma, Li Qun ^a   Liu, Chao ^a,b,c   Wang, Fang ^a,b,c   Xie, Na ^a   Gu, Jun ^a   Fu, Hui ^a,b,c   Wang, Jiang Hua ^a   Cai, Fei ^a   Liu, Jue ^a   Chen, Jian Guo ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; ALPHA 1 ADRENERGIC RECEPTOR; CALCINEURIN; CALCIUM CHANNEL; CALCIUM ION; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STRIATE CORTEX;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ANIMALS, NEWBORN; BENZAZEPINES; BIOPHYSICS; CALCINEURIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENZYME INHIBITORS; FEMALE; GLUTAMATE DECARBOXYLASE; HEPARIN; MALE; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SUBSTANCE P; TYPE C PHOSPHOLIPASES;

EID: 65649143528     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.90345.2008     Document Type: Article

References (58)

1. Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364: 33-41, 1999a. (Pubitemid 29015784)
2. Andringa G, Stoof JC, Cools AR. Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology 146: 328-334, 1999b.
3. 2+-activated phosphatase in mammalian brain. Trends Neurosci 12: 117-122, 1989.
4. 2+ currents in acutely isolated, adult rat neostriatal neurons. J Neurosci 14: 6667-6686, 1994.
5. Beech DJ, Bernheim L, Hille B. Pertussis toxin and voltage dependence distinguish multiple pathways modulating calcium channels of rat sympathetic neurons. Neuron 8: 97-106, 1992.
6. Belmeguenai A, Hansel C. A role for protein phosphatases 1, 2A, and 2B in cerebellar long-term potentiation. J Neurosci 25: 10768-10772, 2005. (Pubitemid 41681925)
7. 2+ channels in nerve terminals of the neurohypophysis. J Neurosci 17: 5772-5781, 1997.
8. Brehm P, Eckert R. Calcium entry leads to inactivation of calcium channel in Paramecium. Science 202: 1203-1206, 1978.
9. Brown AM. A cellular logic for G protein-coupled ion channel pathways. FASEB J 5: 2175-2179, 1991.
10. Chen J, Daggett H, De Waard M, Heinemann SH, Hoshi T. Nitric oxide augments voltage-gated P/Q-type Ca(2+) channels constituting a putative positive feedback loop. Free Radic Biol Med 32: 638-649, 2002.
11. Day M, Olson PA, Platzer J, Striessnig J, Surmeier DJ. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. J Neurophysiol 87: 2490-2504, 2002.
12. Deveney AM, Waddington JL. Pharmacological characterization of behavioural responses to SKF 83959 in relation to "D1-like" dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116: 2120-2126, 1995.
13. Falk T, Zhang S, Erbe EL, Sherman SJ. Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture. J Comp Neurol 494: 275-289, 2006. (Pubitemid 41798086)
14. Frace AM, Hartzell HC. Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes. J Physiol 472: 305-326, 1993.
15. Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat-relationship to circling behaviour. Biochem Pharmacol 49: 1185-1193, 1995.
16. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 174: 3-16, 2004.
17. Henderson LP, Lin L, Prasad A, Paul CA, Chang TY, Maue RA. Embryonic striatal neurons from niemann-pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J Biol Chem 275: 20179-20187, 2000. (Pubitemid 30441629)
18. 2+ currents and excitability via a novel PLC-[beta]1-IP3-calcineurin-signaling cascade. J Neurosci 20: 8987-8995, 2000.
19. Hille B. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci 17: 531-536, 1994. (Pubitemid 124000831)
20. 2+ requirement, and regulation of M current. J Gen Physiol 126: 243-262, 2005.
21. Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature 380: 255-258, 1996.
22. Jin LQ, Goswami S, Cai G, Zhen X, Friedman E. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 85: 378-386, 2003. (Pubitemid 36438333)
23. Lee A, Wong ST, Gallagher D, Li B, Storm DR, Scheuer T, Catterall WA. Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399: 155-159, 1999. (Pubitemid 129524347)
24. Li L. The biochemistry and physiology of metallic fluoride: action, mechanism, and implications. Crit Rev Oral Biol Med 14: 100-114, 2003.
25. Lin F, Xin Y, Wang J, Ma L, Liu J, Liu C, Long L, Wang F, Jin Y, Zhou J, Chen J. Puerarin facilitates Ca(2+)-induced Ca(2+) release triggered by KCl-depolarization in primary cultured rat hippocampal neurons. Eur J Pharmacol 570: 43-49, 2007.
26. Liu YF, Civelli O, Zhou QY, Albert PR. Cholera toxin-sensitive 3′,5′-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. Mol Endocrinol 6: 1815-1824, 1992.
27. 2+ channels in NG108-15 (rodent neuroblastoma x glioma hybrid) cells. J Physiol 510: 371-385, 1998.
28. Martella G, Spadoni F, Sciamanna G, Tassone A, Bernardi G, Pisani A, Bonsi P. Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum. Neuroscience 2008.
29. McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 74: 365-507, 1994. (Pubitemid 24127646)
30. 2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons. J Neurochem 98: 1316-1323, 2006.
31. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 78: 189-225, 1998. (Pubitemid 28070979)
32. Mulkey RM, Endo S, Shenolikar S, Malenka RC. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369: 486-488, 1994. (Pubitemid 2088233)
33. Neve KA, Seamans JK, Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 24: 165-205, 2004. (Pubitemid 39332216)
34. Norris CM, Blalock EM, Chen KC, Porter NM, Landfield PW. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. Neuroscience 110: 213-225, 2002.
35. O'Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, Waddington JL. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions. Synapse 55: 201-211, 2005.
36. Pacheco MA, Jope RS. Comparison of [3H]phosphatidylinositol and [3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem 69: 639-644, 1997.
37. Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol 15: 257-265, 2005. (Pubitemid 40806436)
38. Rane SG, Dunlap K. Kinase C activator 1,2-oleoylacetylglycerol attenuates voltage-dependent calcium current in sensory neurons. Proc Natl Acad Sci USA 83: 184-188, 1986. (Pubitemid 16141638)
39. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci 104: 654-659, 2007. (Pubitemid 46123080)
40. Riedel G. If phosphatases go up, memory goes down. Cell Mol Life Sci 55: 549-553, 1999. (Pubitemid 29221589)
41. Segal M, Greenberger V, Korkotian E. Formation of dendritic spines in cultured striatal neurons depends on excitatory afferent activity. Eur J Neurosci 17: 2573-2585, 2003.
42. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 23: 10093-10099, 2003. (Pubitemid 37392556)
43. Surmeier DJ, Bargas J, Hemmings HC, Jr, Nairn AC, Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14: 385-397, 1995.
44. Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Annu Rev Neurosci 17: 551-567, 1994. (Pubitemid 24117042)
45. Tang TS, Bezprozvanny I. Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons. J Biol Chem 279: 42082-42094, 2004.
46. Tedford HW, Zamponi GW. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 58: 837-862, 2006.
47. Tsien RW, Lipscombe D, Madison D, Bley K, Fox A. Reflections on Ca(2+)-channel diversity, 1988-1994. Trends Neurosci 18: 52-54, 1995.
48. Umemori H, Inoue T, Kume S, Sekiyama N, Nagao M, Itoh H, Nakanishi S, Mikoshiba K, Yamamoto T. Activation of the G protein Gq/11 through tyrosine phosphorylation of the alpha subunit. Science 276: 1878-1881, 1997.
49. Undie AS, Weinstock J, Sarau HM, Friedman E. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62: 2045-2048, 1994. (Pubitemid 24121903)
50. 2+ channels in GH3 cells: direct evidence against dephosphorylation by calcineurin. J Membr Biol 156: 53-61, 1997.
51. Waddington JL, O'Tuathaigh C, O'Sullivan G, Tomiyama K, Koshikawa N, Croke DT. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology 181: 611-638, 2005. (Pubitemid 41400749)
52. Yan Z, Feng J, Fienberg AA, Greengard P. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci USA 96: 11607-11612, 1999.
53. Yu Y, Wang JR, Sun PH, Guo Y, Zhang ZJ, Jin GZ, Zhen X. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action. J Neurochem 104: 946-956, 2008.
54. Zeilhofer HU, Blank NM, Neuhuber WL, Swandulla D. Calcium-dependent inactivation of neuronal calcium channel currents is independent of calcineurin. Neuroscience 95: 235-241, 2000.
55. Zhang H, Ma L, Wang F, Chen J, Zhen X. Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neuropharmacology 53: 125-133, 2007. (Pubitemid 47125943)
56. Zhang ZJ, Jiang XL, Zhang SE, Hough CJ, Li H, Chen JG, Zhen XC. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm. Neurosci Lett 382: 134-138, 2005. (Pubitemid 40725880)
57. Zhen X, Goswami S, Friedman E. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959. Pharmacol Biochem Behav 80: 597-601, 2005. (Pubitemid 41583208)
58. Zhu Y, Yakel JL. Calcineurin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons. J Neurophysiol 78: 1161-1165, 1997. (Pubitemid 27353575)